WallStreetZenWallStreetZen

NASDAQ: ALDX
Aldeyra Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aldeyra Therapeutics earnings were -$57.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ALDX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$9.9M, down 37.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ALDX reported annual earnings of -$55.9M, with 48.8% growth.

ALDX earnings history

Current Revenue
$0.0
Current Earnings
-$57.7M
Current Profit Margin
0%

ALDX Return on Equity

Current Company
-72.6%
Current Industry
-60.2%
Current Market
31.5%
ALDX's Return on Equity (-72.6%)... subscribe to Premium to read more.
High Return on Equity Performance

ALDX undefined

Current Company
-52.3%
Current Industry
-2.5%
ALDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ALDX announces earnings.

ALDX undefined

Current Company
-70.7%
Current Industry
5.8%
ALDX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALDX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ALDX-$55.54M-$57.70MN/A-$0.97
PBYI$54.66M$38.07M+177.49%$0.77
CYBN-$71.77M-$72.16MN/A-$3.41
SLS-$26.56M-$27.13MN/A-$0.38
EDIT-$254.44M-$251.23MN/A-$3.04
View Top Biotech Stocks

Aldeyra Therapeutics Earnings Reports & History FAQ

What were Aldeyra Therapeutics's earnings last quarter?

On ALDX's earnings call on Invalid Date, Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 2025 earnings per share (EPS) of -$0.17, up 21.43% year over year. Total ALDX earnings for the quarter were -$9.93 million. In the same quarter last year, Aldeyra Therapeutics's earnings per share (EPS) was -$0.14.

If you're new to stock investing, here's how to buy Aldeyra Therapeutics stock.

Is Aldeyra Therapeutics profitable or losing money?

As of the last Aldeyra Therapeutics earnings report, Aldeyra Therapeutics is currently losing money. Aldeyra Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$57.70 million, a 92.27% increase year over year.

What was ALDX's earnings growth in the past year?

As of Aldeyra Therapeutics's earnings date in Invalid Date, Aldeyra Therapeutics's earnings has grown year over year. ALDX earnings in the past year totalled -$57.70 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.